The Scientific and Capital Innovation Summit and Conference on the Launch of the R&D Cooperation and Innovation Platform were held in Tianjin. Over 200 participants discussed new investment opportunities in the health industry from different perspectives, while the summit also witnessed the establishment of a new platform for cross-industrial cooperation. At the forum, Tasly declared that it will unite with Bioclub to build an innovation platform.

Capital-driven innovation

“The golden era for investing in one health industry has come,” said Yan Kaijing at the opening paragraph of his report. Only when innovation is combined with capital and a new service mechanism, can it be fully brought into play.

According to Yan, Tasly will build a consumer-centered, one-stop health ecosystem that will provide innovative health products and services. Tasly has developed six core businesses: modern biomedicine, traditional Chinese medicine, healthcare, medical rehabilitation and health management, children's education and health management, and international business. Tasly has further expanded its businesses through mergers and acquisitions, striving to develop biotechnology and information technology that propels the development of the health industry, including e-commerce in pharmaceuticals and genetic testing.

As stated by Yan, it took Tasly seven years to build an investment platform. Aiming to develop its existing businesses, Tasly’s current focus is to allocate resources efficiently and maximize project value.

“We hope to enhance understanding of intersecting fields by establishing a platform for exchange of ideas among experts,” said Yan. Talsy aims to work with third parties, drawing on its capacity and resources to conceive and develop projects to increase the odds of success.

Yan added that Tasly will create an asset portfolio by making use of capital, fostering effective business models and leveraging diversified tools in the capital market. By doing this, it will consolidate resource integration in the industrial ecosystem.

The promising platform of innovation

On the morning of May 8, Tasly and Bioclub launched the Tasly innovation platform.

Bioclub is the largest innovative eco-platform that combines the Internet and health in China. It is dedicated to establishing a globalized incubation ecosystem, gathering resources for startups and assisting them in overcoming difficulties. Bioclub provides entrepreneurs with a comprehensive online service that has zero cost and allows easy access to facilitate innovative results and business growth.

Bioclub's main businesses include O2O brand services, investment, innovation services, incubation services, and startup training. It adopts a self-organizing model in Beijing, Tianjin, Shanghai and Shenzhen, and is recruiting partners overseas. It provides services including cloud incubation, and aspires to cover the entire global network. At present, Bioclub has established connections with over 1,000 investment institutions and over 100,000 entrepreneurs in the health sector.

The innovation platform, upon its completion, will boost Tasly's advantages and accumulate practical experiences in medical research and development. It will also draw on Bioclub's extensive high-end social resources to attract investments and projects on biomedicine and e-health. The platform will bring internal and external expert resources together, link R&D with funds and build interactive channels for products and projects.

Yan hopes that by tapping into Bioclub's influential network, Tasly can interact more efficiently with more resources and effectively boost its R&D capabilities.